Selank + Semax 20MG

This 20MG blend combines Selank and Semax — the two most published peptides of the Russian nootropic-peptide tradition — into a single research presentation. The pairing reflects how these compounds are most often discussed in the literature: Selank, the tuftsin-derived heptapeptide studied in anxiolytic and immunomodulatory paradigms, alongside Semax, the ACTH-fragment analog investigated in nootropic and neuroprotective models. Researchers studying the two together are typically interested in comparative neurochemistry — how two short regulatory peptides with different parent molecules and receptor hypotheses produce overlapping yet distinct behavioral and molecular signatures. A pre-formulated blend ensures fixed ratios across experimental cohorts, which matters for reproducibility when the research question concerns combined or comparative effects rather than isolated pharmacology. Applications include behavioral-model batteries, neurotrophin-expression studies, and screening cascades benchmarking novel nootropic candidates. The pairing captures the two dominant branches of the nootropic-peptide tradition in a single fixed-ratio presentation. For laboratory research use only. Not for human or veterinary use.